Prostate Check – €179
Our new prostate profile, designed by our R&D team and widely published, combines traditional TPSA and FPSA with a novel combination of serum markers. This innovative approach helps triage patients into “low-” and “high-risk” categories, allowing general practitioners to improve patient management in primary care and potentially reduce unnecessary, invasive, and costly treatments.
